Hologic Inc. logo

Hologic Inc. (HOLX)

Market Closed
5 Dec, 20:00
NASDAQ (NGS) NASDAQ (NGS)
$
74. 97
+0.11
+0.15%
$
16.67B Market Cap
38.79 P/E Ratio
0% Div Yield
1,652,346 Volume
3.91 Eps
$ 74.86
Previous Close
Day Range
74.83 75.09
Year Range
51.9 80.31
Want to track HOLX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Hologic (HOLX) Q1 Earnings Surpass Estimates

Hologic (HOLX) Q1 Earnings Surpass Estimates

Hologic (HOLX) came out with quarterly earnings of $1.03 per share, beating the Zacks Consensus Estimate of $1.02 per share. This compares to earnings of $0.98 per share a year ago.

Zacks | 10 months ago
Hologic cuts annual revenue forecast on weak demand for breast health products

Hologic cuts annual revenue forecast on weak demand for breast health products

Hologic lowered its fiscal 2025 revenue forecast, citing weakness in sales of its breast health products, sending the company's shares down 5% after the bell on Wednesday.

Reuters | 10 months ago
Hologic (HOLX) is a Top-Ranked Value Stock: Should You Buy?

Hologic (HOLX) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Zacks | 10 months ago
Countdown to Hologic (HOLX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Countdown to Hologic (HOLX) Q1 Earnings: A Look at Estimates Beyond Revenue and EPS

Get a deeper insight into the potential performance of Hologic (HOLX) for the quarter ended December 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.

Zacks | 10 months ago
Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Investors Heavily Search Hologic, Inc. (HOLX): Here is What You Need to Know

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks | 10 months ago
Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth

Hologic (HOLX) Reports Next Week: Wall Street Expects Earnings Growth

Hologic (HOLX) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Zacks | 10 months ago
Breast Health Performance Likely to Aid Hologic's Q1 Earnings

Breast Health Performance Likely to Aid Hologic's Q1 Earnings

In the first quarter of fiscal 2025, HOLX is expected to have benefited from expanding breast health offerings.

Zacks | 10 months ago
Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know

Hologic (HOLX) Stock Falls Amid Market Uptick: What Investors Need to Know

Hologic (HOLX) concluded the recent trading session at $71.77, signifying a -1.35% move from its prior day's close.

Zacks | 10 months ago
Hologic's Q1 Earnings Coming Up: How to Play the Stock?

Hologic's Q1 Earnings Coming Up: How to Play the Stock?

In the first quarter of fiscal 2025, HOLX is expected to have benefited from the strength of its core franchises.

Zacks | 10 months ago
Why Hologic (HOLX) Outpaced the Stock Market Today

Why Hologic (HOLX) Outpaced the Stock Market Today

In the closing of the recent trading day, Hologic (HOLX) stood at $71.19, denoting a +1.17% change from the preceding trading day.

Zacks | 10 months ago
Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Here is What to Know Beyond Why Hologic, Inc. (HOLX) is a Trending Stock

Recently, Zacks.com users have been paying close attention to Hologic (HOLX). This makes it worthwhile to examine what the stock has in store.

Zacks | 10 months ago
Hologic: Reasonably, But Not Compellingly Valued

Hologic: Reasonably, But Not Compellingly Valued

Hologic, Inc. is down approximately 20% from recent highs despite strong quarterly results. The company continues to grow organically and via a series of 'bolt-on' acquisitions.  Management also recently added significantly to the company's stock buyback authorization. An updated analysis around Hologic, Inc. follows in the paragraphs below.

Seekingalpha | 10 months ago
Loading...
Load More